NMRA Neumora Therapeutics, Inc.
Company Analysis
Latest News
🔴 NMRA makes sharp 10.9% drop
NMRA is trading at $1.44, down 10.9% versus the comparison close of $1.61 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 NMRA is trading 8.2% down today as selling persists after drug failures and restructuring
NMRA is trading 8.2% down at $1.48 as investors continue to sell following the company’s late-stage depression drug failures and restructuring moves. • The...
Neumora's Depression Drug Struck Out Three Times — Can a Gutted Biotech Pivot Its Way Back From the Brink?
Shares of Neumora Therapeutics sank another 10.1% to $1.45 in pre-market trading Tuesday, extending a brutal selloff that has erased roughly 95% of the stock's...
🔴 NMRA is trading 10.1% down today after Phase 3 trial failures and ongoing legal probes
NMRA is trading at $1.45 (10.1% down) in pre-market, extending recent volatility after its lead depression drug navacaprant failed multiple Phase 3 KOASTAL...
🔴 Neumora Therapeutics, Inc. is trading 9.9% down today, extending recent volatility after last week’s extreme swings
Neumora Therapeutics, Inc. is trading 9.9% down at $1.36 in pre-market, extending its recent volatility after last week’s extreme swings. • The decline...
🔴 Neumora Therapeutics, Inc. is trading 5.2% down today following Phase 3 trial failures and workforce reductions
Neumora Therapeutics, Inc. is trading 5.2% down at $1.45, extending a sharp sell-off triggered by the failure of its lead depression drug candidate. • The...